Dr. Nikesh Shah is a hematologist/oncologist at Tampa General Hospital who specializes in hematologic malignancies, particularly lymphomas. Prior to joining Tampa General, Dr. Shah served as a chief fellow for the hematology/oncology fellowship program at Moffitt Cancer Center and the University of South Florida in Tampa. He completed the J. Willis Hurst Internal Medicine Residency Program at Emory University School of Medicine in Atlanta after receiving his medical degree from the University of Miami Leonard M. Miller School of Medicine in Miami, FL.
Dr. Shah is dedicated to developing close relationships with his patients and their families, providing them with a full understanding of each disease and determining the best personalized care for each patient. He enjoys conducting clinical research to identify the most cutting-edge treatment options available and has been credited with several peer-reviewed publications, presentations, abstracts, and book chapters in areas of his expertise.
Dr. Shah has memberships with the American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research, Florida Society of Clinical Oncology and the Florida Medical Association.
American Board of Internal Medicine
CONDITIONS TREATED:
Acute lymphoblastic leukemia/lymphoma
Hematologic malignancies
Hodgkin lymphoma
Non-Hodgkin lymphoma
TREATMENTS OFFERED:
Cellular therapies (CAR-T, anticipated in 2023)
Chemotherapy
Immunotherapy
Intrathecal chemotherapy
Targeted therapy
University of Miami Miller School of Medicine (Miami, FL)
RESIDENCY
Internal Medicine, Emory University (Atlanta, GA)
FELLOWSHIP
Chief Fellow, Hematology and Medical Oncology
H. Lee Moffitt Cancer Center and Research Institute (Tampa, FL)